Risk Stratification of COVID-19 Patients Discharged From the Emergency Department

NCT04629183 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 742

Last updated 2021-07-21

No results posted yet for this study

Summary

Risk stratification of COVID-19 patients is essential to define their appropriate treatment setting. So far, available studies have focused on morbidity and mortality prediction in patients admitted to hospital. In the Emergency Department (ED), decision on home discharge versus hospital admission for COVID-19 is cumbersome. While facing a dramatic second wave of SARS-CoV-2, shortage of hospital beds has further increased the challenge.

The present study will prospectively evaluate the clinical outcomes of patients discharged from the ED. Stratification will be based on a composite of demographic, clinical and lung imaging variables. Results will be used to develop standardized decision rules for safe home discharge of patients with COVID-19 evaluated in the ED.

Conditions

  • Covid19

Interventions

OTHER

integrated clinical evaluation

30-day follow-up (telephone/database query) to define outcome Patients will receive standard care, independent of study participation.

Sponsors & Collaborators

  • University of Turin, Italy

    collaborator OTHER
  • A.O.U. Città della Salute e della Scienza

    lead OTHER

Principal Investigators

  • Fulvio Morello, MD, PhD · A.O.U. Città della Salute e della Scienza di Torino

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2021-01-11
Completion
2021-02-11

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04629183 on ClinicalTrials.gov